絞り込み

16315

広告

「"dahle j"[Author]」の検索結果

68件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Realistic multi-cellular dosimetry for (177)Lu-labelled antibodies: model and application.

Red Marrow Absorbed Dose for non-Hodgkin's Lymphoma Patients treated with the novel anti-CD37 antibody radionuclide conjugate 177Lu-lilotomab satetraxetan.

Tumor Absorbed Dose for non-Hodgkin's Lymphoma Patients treated with the novel anti-CD37 antibody radionuclide conjugate 177Lu-lilotomab satetraxetan.

Treatment of breast cancer with simultaneous integrated boost in hybrid plan technique : Influence of flattening filter-free beams.

Heart dose reduction in breast cancer treatment with simultaneous integrated boost : Comparison of treatment planning and dosimetry for a novel hybrid technique and 3D-CRT.

Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma.

177Lu-DOTA-HH1, a Novel Anti-CD37 Radio-Immunoconjugate: A Study of Toxicity in Nude Mice.

Advantage of Lutetium-177 versus Radioiodine Immunoconjugate in Targeted Radionuclide Therapy of B-cell Tumors.

Modifications in Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters After α-Particle-Emitting (227)Th-trastuzumab Therapy of HER2-Expressing Ovarian Cancer Xenografts.

Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice.

Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 Positive SKBR-3 Xenografts.

Evaluating Antigen Targeting and Anti-tumor Activity of a New Anti-CD37 Radioimmunoconjugate Against Non-Hodgkin's Lymphoma.

Biodistribution and Dosimetry of 177Lutetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma.

A laboratory inter-comparison of the importance of serum serotonin levels in the measurement of a range of radiation-induced bystander effects: Overview of study and results presentation.

Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting (227)Th-DOTA-p-benzyl-trastuzumab.

The role of serotonin and p53 status in the radiation-induced bystander effect.

Transcriptional responses in irradiated and bystander fibroblasts after low dose α-particle radiation.

Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts.

Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates.

  1. 1
  2. 2
  3. 3
  4. 4
Sort by
※並べ替えは表示に時間がかかります